StockData
Vertex Pharmaceuticals Inc logo

Vertex Pharmaceuticals Inc

VRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026Score 15/3037% above fair value
$553.15−5.73 (-1.03%)

Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –

Vertex Pharmaceuticals Workforce by geography

Workforce by geography — Europe employees (standalone FY2015–FY2017, headcount)

Vertex Pharmaceuticals Workforce by geography: 375.00 employees in FY2017, up 7.1% from a year earlier. No newer figure appears in the documents we track.

Latest, FY2017
375.00
Period ended Dec 31, 2017
Change on a year earlier
+7.1%
350.00 in FY2016
History
3 years
Since FY2015
Sources
3
Documents cited below

Where the FY2017 figure comes from

“Of these employees, approximately 1,870 were based in the United States and approximately 375 were based in Europe.”

Source: Form 10-K (a201710k-main.htm, filed 2018-02-15) ↗

Reported in Form 10-K Item 1 (Business — Employees, FY2015–FY2017).

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedWorkforce by geography — Europe employees (standalone FY2015–FY2017, headcount)Year on yearSource
FY2017Dec 31, 2017375.00+7.1%Form 10-K (a201710k-main.htm, filed 2018-02-15) ↗
FY2016Dec 31, 2016350.00+27.3%Form 10-K (a201610k-main.htm, filed 2017-02-23) ↗
FY2015Dec 31, 2015275.00–Form 10-K (a201510k-main.htm, filed 2016-02-16) ↗

Cite this data

StockData. (2026). Vertex Pharmaceuticals Workforce by geography, annual FY2015–FY2017 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/emp-europe

See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.